PHD Biosciences (PHD) is a New York City based biosciences company developing small molecule therapeutics and dermatological products for diseases with high unmet medical need. The PHD research pipeline is complimented by revenue from 14 awards that total more than $7.5 million since 2011. These include: several Small Business Innovation Research (SBIR) awards from the National Cancer Institute (NCI), and National Heart Lung and Blood Institute (NHLBI), a Small Business Technology Transfer (STTR) award from the NCI, funding from the Avon Foundation for Women, and three Center for Advanced Technology awards from New York State.
SMALL MOLECULE THERAPEUTICS
The PHD small molecule program is developing targeted therapeutics for oncology, sickle cell disease, and cystic fibrosis. These compounds demonstrate impressive efficacy and extremely low toxicity. Please see the INNOVATIONS page for information.
OTC AND SKIN CARE PRODUCTS
INFO@PHDBIOSCIENCES | 646.801.3872 | 14 EAST 4TH STREET, SUITE 811, NEW YORK, NY 10012 ©2016 PHDBIOSCIENCES